<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00844584</url>
  </required_header>
  <id_info>
    <org_study_id>xinzangwaike0001</org_study_id>
    <nct_id>NCT00844584</nct_id>
  </id_info>
  <brief_title>Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope</brief_title>
  <official_title>Clinical Study of Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation (AF) is a common supraventricular arrhythmia, the incidence of which
      increases with age. The aim of treatment of atrial fibrillation is to restore sinus rhythm
      and return the heart to atrioventricular synchrony, avoiding the risk of thromboembolism. The
      fact that pharmacological therapy of AF is at best 50% effective has led to a search for
      surgical approaches over the last 20 years.

      Maze procedure was a classic method to treat AF. However, it is such a complex procedure that
      very few surgeons have adopted it. A few minimally invasive procedures to create transmural
      lesions which mimic MAZE procedure have been introduced. One of the mostly favored methods is
      catheter-based radiofrequency ablation, another one is video assisted epicardial
      radiofrequency ablation through small thoracic incisions in operating room.

      Recently, we invented an epicardial radiofrequency ablation method under totally
      thoracoscope, which further minimized the surgery trauma and increased the cosmetic effect.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Electrocardiography</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>ablation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients with atrial fibrillation underwent radiofrequency ablation with totally thoracoscope.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>epicardial radiofrequency ablation</intervention_name>
    <description>epicardial radiofrequency ablation to treat atrial fibrillation under totally thoracoscope</description>
    <arm_group_label>ablation</arm_group_label>
    <other_name>radiofrequency ablation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patients with atrial fibrillation

        Exclusion Criteria:

          -  Patients with hemostasis defects

          -  patients can not endure general anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dinghua Yi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Xijing Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhenxiao Jin, MD</last_name>
    <phone>86-29-84771022</phone>
    <email>jinzx10262@yahoo.com.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dinghua Yi, MD</last_name>
    <phone>86-29-84775307</phone>
    <email>yidinghua@yahoo.com.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Cardiovascular Surgery, Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shannxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dinghua Yi, MD</last_name>
      <phone>86-29-84775307</phone>
      <email>yidinghua@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Zhenxiao Jin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xuezeng Xu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shiqiang Yu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2009</study_first_submitted>
  <study_first_submitted_qc>February 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2009</study_first_posted>
  <last_update_submitted>February 12, 2009</last_update_submitted>
  <last_update_submitted_qc>February 12, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2009</last_update_posted>
  <responsible_party>
    <name_title>Jin Zhenxiao</name_title>
    <organization>Xijing Hospital</organization>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>radiofrequency</keyword>
  <keyword>totally thoracoscope</keyword>
  <keyword>epicardial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

